NEJM Interview: Dr. Peter Marks on the FDAs experience with emergency use authorizations during the Covid-19 pandemic.

Published: March 29, 2023, 3:01 p.m.

Dr. Peter Marks is the director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.W. Marks, H.D. Marston, and L.R. Baden. End of a Declared Public Health Emergency \u2014 Implications for U.S. Emergency Use Authorizations. N Engl J Med 2023;388:1153-1155.